Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS-CoV-2)
is associated with a heightened risk of thrombotic events. 1 We sought to report the …

… to better identify patients at high risk of vascular events who could clearly benefit of a more
aggressive antiplatelet strategy and to reduce the number of false positive patients who would …

… VTE), including deep vein thrombosis (DVT) and/or pulmonary embolism (PE), frequently
occur in patients with severe COVID-19 infection and as with most venous thrombotic events, is …

… the risk of a recurrent thrombotic event in 474 patients who had … a thrombotic event were
investigated and these patients were … However, a positive result of a defect does not predict the …

… In our institute, thrombotic events occurred in two of four patients who were LA-positive
and were … was performed for most ITP patients, and TPO-r agonist was withheld in LA-positive …

Introduction Thrombotic events (TE) appear to be more common in acute promyelocytic
leukemia (APL) than in other acute leukemias, with reported prevalence ranging from 2 to10-15%…

… in eight patients with APS. As shown in Table 1, all patients had venous thrombosis as the
… had a previous arterial event (renal infarction and stroke) and three tested positive for the …

… Thrombotic events were reported in up to 23% of patients … up to 16% of patients treated
with bevacizumab in combination … have been positively tested in drug-eluting coronary stents. …

… designs, patient selection criteria, aPL profiles and the risk factors considered.2 – 7 … thrombotic
event and the efficacy of primary prophylactic treatments in a large number of aPL positive …

… thrombotic events … patients with thrombotic events [3/11 (27.3%) vs. 3/93 (3.2%), p = 0.015)].
Lupus anticoagulant was found to be positive in 60% (3/5) of patients with thrombotic event …